polatuzumab vedotin
Drug timelines are a Plus or Pro feature.
36 regulatory and trial events tracked for polatuzumab vedotin, covering 2017-06-16 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011) [Phase 2]